MMJ Marijuana Waiting FDA Approved Huntington's Clinical Trials As RFK Jr.'s Push to Conduct Scientific Research
MMJ's innovative soft gelatin THC-CBD capsule, known as MMJ-002, is undergoing the rigorous FDA approval process to ...
FDA Approves New Tablet Form of Evrysdi for Treatment of Spinal Muscular Atrophy
About Evrysdi Evrysdi is an SMN2-splicing modifier designed to increase functional SMN protein production. With the introduction of a new tablet formulation, Evrysdi now offers an alternative ...
What a $2 million per dose gene therapy reveals about drug pricing
Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...
Ozempic shown to reduce drinking in first trial in alcohol-use disorder
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
Science Friday1d
The FDA Approves A New, Non-Opioid Painkiller
Here to help break down this new painkiller is Dr. Sean Mackey. He’s a Professor of Anesthesiology and Medicine at Stanford ...
Anesthesiologists' Group Urges Limits on Ketamine Use
As the ASA noted, the U.S. Food and Drug Administration (FDA) has never approved ketamine for any use other than anesthesia. Still, there's been a recent surge in "off-label" use of the infused or ...
What’s Really in Your Dog’s Food?
CR tested 58 dog foods from brands including Blue Buffalo, Hill’s Science Diet, and Purina for key nutrients and dangerous ...
manilatimes6d
FDA Approves New Tablet Form of Evrysdi for Treatment of Spinal Muscular Atrophy
This new formulation provides an additional treatment option ... effective and convenient therapies,” said Sharon Hesterlee, PhD, EVP, Chief Research Officer, MDA. "The approval of the tablet ...
Morningstar6d
FDA Approves New Tablet Form of Evrysdi for Treatment of Spinal Muscular Atrophy
New York, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today celebrates the decision by the US Food and Drug Administration (FDA ... Research Officer, MDA. “The ...
C&EN5d
FDA approves drug for neurofibromatosis
The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults and children. The drug, developed by SpringWorks Therapeutics, is the ...